IV Anti-thymocyte globuline [clinicaltrials_resource:27aa57467883a9a85e86a9fee44455de]
intervention [clinicaltrials_vocabulary:intervention]
IV Anti-thymocyte globuline [clinicaltrials_resource:27aa57467883a9a85e86a9fee44455de]
Bio2RDF identifier
27aa57467883a9a85e86a9fee44455de
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:27aa57467883a9a85e86a9fee44455de
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
(Thymogobuline®, 2.5 mg/kg/day for 2 days) (Day-3 and -2)
intervention name [clinicaltrials_vocabulary:intervention-name]
IV Anti-thymocyte globuline
other name [clinicaltrials_vocabulary:other-name]
Anti-thymocyte globuline
identifier
clinicaltrials_resource:27aa57467883a9a85e86a9fee44455de
title
IV Anti-thymocyte globuline
@en
type
label
IV Anti-thymocyte globuline [clinicaltrials_resource:27aa57467883a9a85e86a9fee44455de]
@en